VALGANCICLOVIR相关论文
Valganciclovir for pre-emptive therapy of cytomegalovirus viraemia after hematopoietic stem cell tra
...
一种治疗获得性免疫缺陷综合征 (ＡＩＤＳ)患者巨细胞病毒 (ＣＭＶ)视网膜炎的新药———Ｖａｌｇａｎｃｉｃｌｏｖｉｒ(Ｖａｌｃｙｔｅ,更昔洛韦口服前体药物 )已获准销售 ,该药和静脉更昔洛......
Valganciclovir for pre-emptive therapy of cytomegalovirus viraemia after hematopoietic stem cell tra
Background Despite its widespread use in the management of HIV-related cytomegalovirus (CMV) infection, there have been ......
AIM: To analyze differences in patients’ clinical course, we compared two regimes of either preemptive therapy or proph......
目的探讨缬更昔洛韦是否能够有效预防肺移植术后巨细胞病毒（CMV）感染。方法回顾性分析2015年9月-2017年4月河南省人民医院胸外科收治......
2010年9月15日美国食品药品监督管理局（FDA），提醒医师最新推荐的Valeyte用量，此举是为了防止valganciclovir的器官移植儿童用药过量。......
Cytomegalovirus (CMV) infection is the most important cause of mental retardation and sensorineural hearing loss. Antivi......
Cytomegalovirus(CMV) is one of the most common viral pathogens causing clinical disease in liver transplant recipients, ......
Cytomegalovirus (CMV) is the most common viral pa- thogen that negatively impacts on the outcome of liver transplantatio......
